tiprankstipranks
RegenXBio Inc. (RGNX)
:RGNX
US Market

RegenXBio (RGNX) Income Statement

Compare
901 Followers

RegenXBio Income Statement

Last quarter (Q3 2024), RegenXBio's total revenue was $24.20M, a decrease of -16.31% from the same quarter last year. In Q3, RegenXBio's net income was $-59.60M. See RegenXBio’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 90.24M$ 112.72M$ 470.35M$ 154.57M$ 35.23M
Gross Profit
$ 53.03M$ 58.18M$ 418.51M$ 118.85M$ 26.99M
Operating Expenses
$ 321.16M$ 321.06M$ 258.53M$ 238.09M$ 175.99M
Depreciation and Amortization
$ 17.32M$ 12.91M$ 9.56M$ 8.41M$ 7.15M
EBITDA
$ -239.46M$ -244.24M$ 169.54M$ -96.83M$ -90.34M
Operating Income
$ -268.13M$ -262.88M$ 159.98M$ -119.23M$ -149.00M
Other Income/Expenses
$ 4.48M$ -17.53M$ -18.73M$ 13.22M$ 51.51M
Pretax Income
$ -263.65M$ -280.40M$ 141.25M$ -106.01M$ -97.49M
Net Income
$ -263.49M$ -280.32M$ 127.84M$ -111.25M$ -94.73M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -6.02$ -6.50$ 3.01$ -2.98$ -2.58
Diluted EPS
$ -6.02$ -6.50$ 2.91$ -2.98$ -2.58
Weighted Average Shares Outstanding
43.73M 43.15M 42.44M 37.28M 36.69M
Weighted Average Shares Outstanding (Diluted)
43.73M 43.15M 43.91M 37.28M 36.69M
Currency in USD

RegenXBio Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis